tiprankstipranks
Kyntra Bio (MX:KYNB)
:KYNB
Mexico Market
KYNB
Kyntra Bio
RESEARCH TOOLSreports

Kyntra Bio (KYNB) Ratios

0 Followers

Kyntra Bio Ratios

MX:KYNB's free cash flow for Q2 2026 was $1.00. For the 2026 fiscal year, MX:KYNB's free cash flow was decreased by $ and operating cash flow was $33.57. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.69 3.39 1.47 1.52 1.80
Quick Ratio
 2.59 3.26 1.45 1.33 1.65
Cash Ratio
 1.41 1.64 0.38 0.52 0.57
Solvency Ratio
 1.68 1.60 -0.11 -0.47 -0.46
Operating Cash Flow Ratio
 -1.06 -0.16 -1.04 -1.45 -0.53
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 -7.88K 0.00
Net Current Asset Value
$ -12.40M$ -16.05M$ -201.65M$ -254.17M$ -118.74M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.00 0.42 0.40 0.15
Debt-to-Equity Ratio
 0.00 0.00 -0.40 -0.83 -4.19
Debt-to-Capital Ratio
 0.00 0.00 -0.67 -5.06 1.31
Long-Term Debt-to-Capital Ratio
 0.00 0.00 -0.66 -0.78 0.00
Financial Leverage Ratio
 -3.35 -3.98 -0.95 -2.07 -28.45
Debt Service Coverage Ratio
 -10.12 -6.56 -17.24 -37.49 -196.65
Interest Coverage Ratio
 -5.47 -5.24 -18.24 -39.87 -209.05
Debt to Market Cap
 0.00 0.00 0.07 0.04 0.00
Interest Debt Per Share
 2.29 2.17 0.98 1.83 0.98
Net Debt to EBITDA
 0.54 0.83 -0.28 -0.19 0.23
Profitability Margins
Gross Profit Margin
18.15%91.37%47.47%91.53%85.59%
EBIT Margin
-2040.61%-905.19%-489.92%-673.31%-208.50%
EBITDA Margin
-2036.13%-893.57%-480.83%-652.09%-200.96%
Operating Profit Margin
-1101.02%-712.66%-507.80%-689.53%-213.90%
Pretax Profit Margin
-669.57%-905.19%-517.76%-690.60%-208.40%
Net Profit Margin
3967.77%2848.63%-160.63%-607.29%-208.66%
Continuous Operations Profit Margin
-669.55%-903.79%-516.86%-690.06%-208.66%
Net Income Per EBT
-592.59%-314.70%31.02%87.94%100.12%
EBT Per EBIT
60.81%127.02%101.96%100.16%97.43%
Return on Assets (ROA)
181.24%153.40%-22.18%-67.11%-48.13%
Return on Equity (ROE)
-605.53%-610.73%21.09%139.22%1369.21%
Return on Capital Employed (ROCE)
-78.16%-50.80%-185.20%-156.77%-89.45%
Return on Invested Capital (ROIC)
-78.16%-50.72%-184.87%-146.59%-86.80%
Return on Tangible Assets
181.24%153.40%-22.18%-67.11%-48.13%
Earnings Yield
529.30%516.80%-3.59%-13.18%-0.78%
Efficiency Ratios
Receivables Turnover
 13.31 1.53 61.58 1.14 8.63
Payables Turnover
 0.50 0.15 3.07 0.22 0.66
Inventory Turnover
 1.12 0.15 4.93 0.10 0.50
Fixed Asset Turnover
 0.00 0.00 305.37 0.58 1.40
Asset Turnover
 0.05 0.05 0.14 0.11 0.23
Working Capital Turnover Ratio
 0.07 0.10 0.33 0.28 0.60
Cash Conversion Cycle
 -371.08 237.64 -38.85 2.49K 216.46
Days of Sales Outstanding
 27.43 238.95 5.93 320.16 42.27
Days of Inventory Outstanding
 326.85 2.46K 74.00 3.83K 727.77
Days of Payables Outstanding
 725.36 2.46K 118.78 1.65K 553.58
Operating Cycle
 354.28 2.70K 79.93 4.15K 770.04
Cash Flow Ratios
Operating Cash Flow Per Share
 -9.40 -1.18 -1.38 -3.24 -1.56
Free Cash Flow Per Share
 -9.40 -1.19 -1.38 -3.26 -1.97
CapEx Per Share
 <0.01 <0.01 <0.01 0.03 0.41
Free Cash Flow to Operating Cash Flow
 1.00 1.01 1.00 1.01 1.27
Dividend Paid and CapEx Coverage Ratio
 -4.23K -125.63 -55.29 -125.06 -3.77
Capital Expenditure Coverage Ratio
 -4.23K -125.63 -518.79 -125.06 -3.77
Operating Cash Flow Coverage Ratio
 0.00 0.00 -1.53 -1.85 -1.62
Operating Cash Flow to Sales Ratio
 -8.24 -0.74 -4.66 -6.73 -1.04
Free Cash Flow Yield
-109.97%-13.56%-10.43%-14.73%-0.49%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 0.15 0.19 -27.60 -7.59 -127.63
Price-to-Sales (P/S) Ratio
 7.50 5.51 44.75 46.07 266.32
Price-to-Book (P/B) Ratio
 -1.15 -1.18 -5.88 -10.56 -1.75K
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.91 -7.38 -9.59 -6.79 -202.95
Price-to-Operating Cash Flow Ratio
 -0.91 -7.44 -9.61 -6.84 -256.83
Price-to-Earnings Growth (PEG) Ratio
 <0.01 >-0.01 0.33 1.04 0.00
Price-to-Fair Value
 -1.15 -1.18 -5.88 -10.56 -1.75K
Enterprise Value Multiple
 0.17 0.22 -9.59 -7.25 -132.29
Enterprise Value
 -16.03M -12.37M 1.37B 2.21B 37.41B
EV to EBITDA
 0.17 0.22 -9.59 -7.25 -132.29
EV to Sales
 -3.47 -1.92 46.09 47.28 265.85
EV to Free Cash Flow
 0.42 2.57 -9.87 -6.97 -202.59
EV to Operating Cash Flow
 0.42 2.59 -9.89 -7.02 -256.38
Tangible Book Value Per Share
 -2.01 1.11 -1.84 -1.67 -0.02
Shareholders’ Equity Per Share
 -7.45 -7.43 -2.26 -2.10 -0.23
Tax and Other Ratios
Effective Tax Rate
 <0.01 <0.01 <0.01 <0.01 >-0.01
Revenue Per Share
 1.14 1.59 0.30 0.48 1.50
Net Income Per Share
 45.25 45.38 -0.48 -2.92 -3.14
Tax Burden
 -5.93 -3.15 0.31 0.88 1.00
Interest Burden
 0.33 1.00 1.06 1.03 1.00
Research & Development to Revenue
 4.95 3.65 3.23 5.69 2.11
SG&A to Revenue
 6.11 4.30 1.67 0.00 0.00
Stock-Based Compensation to Revenue
 0.86 1.02 0.85 1.08 0.47
Income Quality
 -0.21 -0.03 2.90 1.11 0.50
Currency in USD